Pro-Dex Inc. (PDEX): רווח למניה בשנים עשר החודשים האחרונים

Stable growth for Pro-Dex, Inc. (PDEX) is driven by conservative management and a debt-free balance sheet. The trailing 12-month net income per share confirms this trend, with 3.68 recorded as the baseline value. The humanitarian status of the industry and localized supply chains guarantee business security. High surgeon confidence in instrument precision solidifies the company's status as a leading developer in the medical field.

Pro-Dex, Inc. (PDEX) is scaling the production of electrosurgical instruments through long-term OEM contracts with medtech giants. This metric recalculates the aggregate net income for a rolling year per common share. By analyzing this 12-month net income per share chart, an investor can see the real return on equity without seasonal fluctuations. The trajectory of the line reflects the efficiency of converting production capacities into profit. Growth in this metric confirms the fundamental undervaluation or fair value of the asset.